Medicinova Stock Price - MNOV

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Medicinova Inc MNOV NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.14 2.05% 6.97 7.09 6.90 6.91 6.83 18:01:25
Bid Price Ask Price Spread Spread % News
5.65 148.80 143.15 96.2% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
1,089 79,446 $ 6.95 $ 552,505 116,458 6.36 - 13.37
Last Trade Time Type Quantity Stock Price Currency
15:59:42 16 $ 6.97 USD

Medicinova Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 305.58M 43.84M $ -14.68M -0.37 - 40.93M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Medicinova News

Loading Messages....

Latest MNOV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNOV Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.897.096.74476.8758,7730.081.16%
1 Month7.157.296.366.90110,437-0.18-2.52%
3 Months8.468.466.367.3297,591-1.49-17.61%
6 Months10.1510.156.367.9794,113-3.18-31.33%
1 Year9.8713.376.369.0797,369-2.90-29.38%
3 Years6.1814.504.409.14106,9750.7912.78%
5 Years3.4514.502.627.56113,2223.52102.03%

Medicinova Description

MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of small molecule therapeutics segment.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.